Sort
172,184 grants matching “inflammation”
Autophagy Modulators as Novel Broad-Spectrum Anti-Infective Agents
$7,381,267Herbert W Virgin · Ut Southwestern Medical Center · U19 · FY2020 · AI
Autophagy Modulators as Novel Broad-Spectrum Anti-Infective Agents
$7,381,267Herbert W Virgin · Ut Southwestern Medical Center · U19 · FY2023 · AI
Autophagy Modulators as Novel Broad-Spectrum Anti-Infective Agents
$7,381,267Herbert W Virgin · Ut Southwestern Medical Center · U19 · FY2022 · AI
Autophagy Modulators as Novel Broad-Spectrum Anti-Infective Agents
$7,381,267Beth C Levine · Ut Southwestern Medical Center · U19 · FY2019 · AI
Autophagy Modulators as Novel Broad-Spectrum Anti-Infective Agents
$7,381,267Herbert W Virgin · Ut Southwestern Medical Center · U19 · FY2021 · AI
EXTREME LONGEVITY FAMILY STUDY
$7,376,403Michael A Province · Washington University · U01 · FY2010 · AG
IGF::OT::IGFEMMES NEIS-V
$7,315,897Keri Hammel · The Emmes Company, Llc · N01 · FY2021 · OD
Inflammation and the Host Response to Injury
$7,310,756Massachusetts General Hospital · U54 · FY2002 · GM
General Clinical Research Center
$7,246,894Richard D Krugman · University Of Colorado Denver · M01 · FY2007 · RR
IGF::OT::IGFEMMES NEIS-V
$7,243,461Keri Hammel · The Emmes Company, Llc · N01 · FY2018 · OD
Study in Parkinson Disease of Exercise Phase 3 Clinical Trial: SPARX3
$7,226,355Daniel M Corcos · Northwestern University At Chicago · U01 · FY2023 · NS
IGF::OT::IGFEMMES NEIS-V
$7,217,805Keri Hammel · The Emmes Company, Llc · N01 · FY2019 · OD
IGF::OT::IGFEMMES NEIS-V
$7,212,964Keri Hammel · The Emmes Company, Llc · N01 · FY2020 · OD
Clarifying the Optimal Application of SLT Therapy (COAST) Trial
$7,182,740Stephen R Wisniewski · University Of Pittsburgh At Pittsburgh · UG1 · FY2024 · EY
Study in Parkinson Disease of Exercise Phase 3 Clinical Trial: SPARX3
$7,159,125Daniel M Corcos · Northwestern University At Chicago · U01 · FY2020 · NS
The Emory Healthy Brain Study: Discovering Predictive Biomarkers for Alzheimer's Disease
$7,138,053James J Lah · Emory University · R01 · FY2022 · AG
The Emory Healthy Brain Study: Discovering Predictive Biomarkers for Alzheimer's Disease
$7,125,379James J Lah · Emory University · R01 · FY2021 · AG
GENERAL CLINICAL RESEARCH CENTER
$7,120,143Richard D Krugman · University Of Colorado Denver · M01 · FY2006 · RR
SPIROMICS II: Biological underpinnings of COPD heterogeneity and progression
$7,089,002Prescott G Woodruff · University Of California, San Francisco · U01 · FY2018 · HL
Sensory Phenotyping to Enhance Neuropathic Pain Drug Development
$7,081,684Roy Freeman · Beth Israel Deaconess Medical Center · UH3 · FY2025 · NS
Prenatal Diagnosis Of Congenital Anomalies
$7,066,657Roberto Romero · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2019 · HD
Dysfunctional lipid metabolism and peroxidation in chronic pain and neurodegeneration
$7,042,784Christopher Ramsden · National Institute On Aging · ZIA · FY2022 · AG
The Emory Healthy Brain Study: Discovering Predictive Biomarkers for Alzheimer's Disease
$7,011,679James J Lah · Emory University · R01 · FY2023 · AG
The Emory Healthy Brain Study: Discovering Predictive Biomarkers for Alzheimer's Disease
$7,011,679James J Lah · Emory University · R01 · FY2024 · AG
National Social Life, Health, and Aging Project: Round 5
$6,976,331Linda J Waite · National Opinion Research Center · R01 · FY2025 · AG